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Mycobacteria-responsive sonic 
hedgehog signaling mediates 
programmed death-ligand 1- and  
prostaglandin E2-induced 
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CD4+CD25+FoxP3+ regulatory T cells (Tregs) are exploited by mycobacteria to subvert the protective 
host immune responses. The Treg expansion in the periphery requires signaling by professional antigen 
presenting cells and in particularly dendritic cells (DC). However, precise molecular mechanisms by 
which mycobacteria instruct Treg expansion via DCs are not established. Here we demonstrate that 
mycobacteria-responsive sonic hedgehog (SHH) signaling in human DCs leads to programmed death 
ligand-1 (PD-L1) expression and cyclooxygenase (COX)-2-catalyzed prostaglandin E2 (PGE2) that 
orchestrate mycobacterial infection-induced expansion of Tregs. While SHH-responsive transcription 
factor GLI1 directly arbitrated COX-2 transcription, specific microRNAs, miR-324-5p and miR-338-5p, 
which target PD-L1 were downregulated by SHH signaling. Further, counter-regulatory roles of SHH 
and NOTCH1 signaling during mycobacterial-infection of human DCs was also evident. Together, our 
results establish that Mycobacterium directs a fine-balance of host signaling pathways and molecular 
regulators in human DCs to expand Tregs that favour immune evasion of the pathogen.
CD4+CD25+FoxP3+ regulatory T cells (Tregs) are one of the subsets of CD4+ T helper cells that are necessary for 
immune homeostasis. Apart from their roles in maintaining peripheral tolerance, Tregs have been heavily impli-
cated for regulating immune responses against the invading pathogens1–3. Exhibiting contrast functions, Tregs 
can not only suppress protective immune responses and the collateral damage caused due the excessive inflam-
mation during infections, but also provide suitable niche for facilitating the persistence of chronic infections 
such as tuberculosis4–6. Thus, induction and expansion of Tregs mark as one of the immune evasion strategies of 
mycobacteria for their survival in the host.
During mycobacterial infections, accumulation and proliferation of Tregs at the site of infection contributes 
to inhibition of bacterial clearance5,7 as well as inhibition of antigen-specific protective responses exhibited by γ δ 
T cells8. Further, patients with active tuberculosis have increased population of circulating Tregs that suppress 
IFN-γ production by Th1 cells9. Correspondingly, ex vivo depletion of Tregs from the PBMCs alleviates the IFN-γ 
production in response to mycobacterial antigens10. While in vivo depletion of CD25+ T cells in mice enhanced 
the IFN-γ production, adoptive transfer of CD25+ T cells to mice infected with M. tuberculosis facilitates bacterial 
survival11. Thus, understanding the mechanisms that define such Treg-mediated survival strategies of mycobac-
teria is important.
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Investigations in both murine and human models of tuberculosis have identified several mechanisms of Treg 
generation and expansion12,13. Of current interest, studies have highlighted the roles for PD-L1 (B7-H1/CD274) 
and COX-2-catalyzed PGE2 during mycobacteria-induced Treg induction and expansion. While PD-L1 deficient 
mice were increasingly sensitive to tuberculosis infection14, studies on human DCs showed that infection-induced 
PD-L1 was essential for expansion of Tregs15,16. Though PD-L1 KO mice exhibited elevated CD4+ T and CD8+ 
T cell responses, PD-1 expression was higher in CD4+ T cells in the PD-L1 KO mice, suggesting a possible sup-
pression of PD-1 by PD-L1. Further, possibly due to chronic activation of immune cells and inflammation, PD-L1 
KO mice exhibited increased mycobacterial CFUs in lung and death of mice14. Likewise, PGE2-responsive human 
Treg expansion was found during mycobacterial infection17. However, the mechanisms that mediate the expres-
sion of the molecules like PD-L1 and COX-2 in DCs are not established.
In this context, it is well constituted that mycobacterial infection of the cells instigates a plethora of signaling 
pathways that ultimately regulate the immune mediators to determine cell-fate decisions and outcome/s of the 
infection. Previous investigations from our laboratory implicates the roles for SHH, WNT, NOTCH1 and PI3K 
signaling pathways in modulating macrophage18–21 and DC22–24 responses. Further, NOTCH25,26, WNT27,28, and 
PI3K29,30 pathways were entailed to regulate the DC functions. Thus, we explored the roles for these signaling 
pathways in modulating the mycobacteria-induced Treg expansion and functions.
Here we demonstrate that infection-responsive activation of SHH-PI3K-mTOR-NF-κ B signaling in human 
DCs was necessary for M. bovis BCG-induced Treg expansion. On the other hand, NOTCH signaling hin-
dered the ability of the infected DCs to expand Tregs while the contribution of WNT signaling was not evident. 
Although no apparent influence of SHH and NOTCH1 signaling on DC phenotype in terms of the maturation 
markers HLA-DR, CD40, CD83, CD80 and CD86 was observed, pro-inflammatory cytokines such as TNF-α , 
IL-2, IL-1β and IL-6 were moderately NOTCH1-responsive and suppressed by SHH signaling. Further, experi-
ments utilizing pharmacological inhibitors and conventional siRNAs indicated that both PD-L1 and COX-2/PGE2 
were induced in DCs upon stimulation with M. bovis BCG and M. tuberculosis and were regulated by SHH sign-
aling. While SHH-responsive transcription factor, GLI1 arbitrated COX-2 expression, mycobacteria-stimulated 
SHH signaling was found to suppress miR-324-5p and miR-338-5p, bonafide miRNAs that target PD-L1, to aid 
increased expression of PD-L1 and Treg expansion. Interestingly, inhibition of NOTCH1 signaling resulted in ele-
vated expression of infection-induced PD-L1 whereas inhibition of SHH signaling showed increased transcripts 
of JAG2 and NICD, markers for NOTCH activation. These results establish the mechanism of Treg expansion 
during mycobacterial infections, a testimony of its survival capabilities in the host.
Results
SHH and NOTCH signaling regulate M. bovis BCG-induced Treg expansion. To investigate the 
molecular circuitry regulating mycobacteria-mediated Treg expansion, role for signaling pathways like NOTCH, 
WNT and SHH were assessed. Twenty-four hours post-infection with M. bovis BCG, DCs were washed and 
co-cultured with autologous CD4+ T cells for 5 days to analyze the expansion of Treg population. As shown in 
Fig. 1a,b, M. bovis BCG-infected DCs induced significant expansion of CD4+CD25+FoxP3+ Treg cells. However, 
DCs pretreated with cyclopamine (SHH pathway inhibitor) failed to induce Treg expansion. Further, treatment 
of DCs with GSI (NOTCH signaling activation inhibitor) enhanced their ability to expand Tregs. Interestingly, 
no significant difference was observed on perturbation of WNT pathway using IWP-2 (a WNT secretion inhibi-
tor). These results suggest that SHH signaling positively regulates M. bovis BCG-mediated CD4+CD25+FoxP3+ 
Treg expansion and on the contrary, NOTCH signaling was found to exhibit negative regulation. Importantly, no 
definite roles for SHH and NOTCH signaling was found in mediating Th1 cell cytokine IFN-γ on M. bovis BCG 
infection (Fig. 1c,d). However, NOTCH signaling was required for infection-induced IL-2 (Fig. 1d). These data 
thus suggest selective role of SHH and NOTCH signaling pathways in modulating human Treg responses without 
disturbing IFN-γ responses. In line with these observations, perturbation of SHH and NOTCH signaling did not 
directly modulate either M. bovis BCG-induced DC maturation (Fig. 2a), or infection-stimulated secretion DC 
cytokines like TNF-α and IL-6 (Fig. 2b). Interestingly, infection-induced Th1-polarizing IL-12p70 was found 
to be SHH and NOTCH signaling dependent. Together, results suggest that while SHH signaling was found to 
be essential for M. bovis BCG-induced CD4+CD25+FoxP3+ Treg expansion, NOTCH signaling suppress Treg 
expansion.
M. bovis BCG-responsive SHH signaling is PI3K-mTOR-NF-κB pathway dependent. To fur-
ther understand the molecular mechanism involved in M. bovis BCG-mediated SHH signaling, the activation 
status of SHH signaling in the DCs was assessed. Stimulation of DCs with M. bovis BCG or M. tuberculosis 
induced significant activation of SHH signaling pathway (Fig. 3a,b). Activation of canonical SHH pathways is 
marked by elevated transcripts of SHH, GLI1 and PTCH1 and increased levels of SHH, GLI1, pGSK-3β (Ser9) and 
decreased NUMB expression. Mycobacteria-stimulated activation of SHH signaling was found to be dependent 
on PI3K-mTOR-NF-κ B pathway as pretreatment of DCs with specific inhibitors of PI3K (LY294002), mTOR 
(Rapamycin) and NF-κ B (BAY 11-7085) led to significant reduction of M. bovis BCG-induced SHH signal-
ing (Fig. 3c,d). Corroborating these results, DCs pretreated with mTOR or NF-κ B specific inhibitors failed to 
expand CD4+CD25+FoxP3+ Treg cells (Fig. 3e). However, PI3K-specific inhibitor had no effect on M. bovis 
BCG-induced CD4+CD25+FoxP3+ Treg cells expansion (Fig. 3e).
SHH signaling-mediated expression of PD-L1 and COX-2-PGE2 is required for Treg expansion. 
Having established that mycobacteria activate the PI3K-mTOR-NF-κ B-SHH signaling cascade in human DCs to 
induce Treg expansion, we attempted to identify the molecular regulators that mediate the process. Utilizing cues 
from previous investigations15–17, we analyzed the role for co-stimulatory molecules PD-L1, PD-L2 and a soluble 
factor such as COX-2-PGE2 in the current study. Stimulation of DCs with M. bovis BCG and M. tuberculosis 
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resulted in increased expression of PD-L1 and PTGS2/COX-2 (Fig. 4a, left panel). In line with our previous 
results, PD-L2 was not induced in stimulated DCs. Further, enhanced COX-2 expression was also associated with 
concomitant increase in PGE2 secretion by DCs (Fig. 4a, right panel). Following the previous results, expression 
of PD-L1 and PTGS2/COX-2 transcripts was found to be PI3K-mTOR-NF-κ B-SHH dependent (Fig. 4b). Further, 
surface expression of PD-L1 (Fig. 4c), expression of COX-2 in the whole cell lysate (Fig. 4d) and secretion of 
PGE2 by DCs (Fig. 4e) followed the similar trend. SHH-mediated expression of these mediators was confirmed 
by reduced expression of PD-L1, COX-2 and PGE2 on M. bovis BCG infection in the presence of SHH-specific 
siRNA (Fig. 4f–i). Finally, inhibition of either PD-L1 or COX-2 by specific blocking antibody (anti-PD-L1) or 
pharmacological inhibitor (NS-398, COX-2 inhibitor) could partially inhibit the M. bovis BCG-induced Treg 
expansion (Fig. 5a). Of note, inhibition of both PD-L1 and COX-2 in DCs significantly suppressed the ability of 
mycobacteria to expand Tregs (Fig. 5b,c).
GLI1, a zinc-finger protein, is a dedicated transcription factor for SHH signaling-mediated gene expres-
sion31. ChIP analysis revealed M. bovis BCG-induced recruitment of GLI1 to the promoter of PTGS2/COX-2 
in DCs suggesting a SHH-dependent transcriptional regulation of COX-2 expression (Fig. 6a). However, no 
apparent change was observed on PD-L1 promoter (Fig. 6a). In this context, we speculated the role for mod-
ulation of negative regulators of PD-L1 by infection-responsive SHH signaling. MiRNAs belong to one such 
class of post-transcriptional regulators. Extensive bioinformatic analysis (TargetScan, miRanda, miRWalk and 
RNAhybrid) together with available cues on downregulated miRNAs in tuberculosis patient20,32 or M. tuber-
culosis or M. bovis BCG samples33 identified miR-15b, miR-324-5p, miR-338-5p and miR-425-5p as candidate 
miRNAs that could target PD-L1. In line with this, DCs infected with M. tuberculosis or M. bovis BCG exhibited 
reduced levels of the identified miRNAs. MiR-155 was utilized as a known positive control (Fig. 6b). However, 
among the M. bovis BCG-downregulated miRNAs, expression of miR-324-5p and miR-338-5p was found to be 
SHH-regulated as the downregulation of miR-324-5p and miR-338-5p was significantly rescued in presence of 
a SHH inhibitor, cyclopamine (Fig. 6c). The target sites located at the residues spanning from 99–106 (for miR-
324-5p) and 526–533 (for miR-338-5p) of the 3′UTR of PD-L1 were identified as critical for miRNA-3′UTR inter-
actions (Fig. 6d). To establish that PD-L1 is the bonafide targets of miR-324-5p and miR-338-5p, we utilized the 
classical 3′UTR luciferase assays. Transfection of a monocytic cell line THP-1 with miR-324-5p or miR-338-5p 
Figure 1. Opposing role of SHH and NOTCH1 signaling during M. bovis BCG-induced Treg expansion. 
(a,b) Immature DCs were cultured in GM-CSF and IL-4 alone (Med) or along with pharmacological inhibitors 
of SHH signaling pathway like Cyclopamine (SMO inhibitor), WNT signaling pathway like IWP-2 (a WNT 
secretion inhibitor) or NOTCH signaling like γ -secretase inhibitor (GSI) for 1 h followed by infection with 
M. bovis BCG (MOI 1:10) for 24 h. After extensive wash, DCs were co-cultured with autologous CD4+ T cells. 
CD4+CD25+FoxP3+ Tregs were analyzed by flow cytometry. (a) Representative dot blot of 6 independent 
experiments is shown. (b) Percentage of CD4+CD25+FoxP3+ cells in the DC-CD4+ T cell co-cultures 
(mean ± SEM, n = 8). (c) In a similar set up as panels (a,b) percentage of IFN-γ +CD4+ cells in the DC-CD4+ T 
cell co-cultures (mean ± SEM, n = 7). (d) T cell cytokines IL-2, TNF-α and IFN-γ were analyzed in the cell-free 
culture supernatants of DC:T cell co-culture (mean ± SEM, n = 6–7) by cytokine bead array. Med, Medium. 
*P < 0.05; **P < 0.005; ***P < 0.001 (one-way ANOVA followed by Turkey’s multiple-comparisons test).
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mimics markedly reduced WT PD-L1 3′UTR luciferase activity. However, no significant reduction was observed 
when mutant construct for miR-324-5p and miR-338-5p binding on PD-L1 3′UTR was utilized (Fig. 6e). These 
results thus validate that PD-L1 is a direct target of miR-324-5p and miR-338-5p. In accordance with this obser-
vation, we found that DCs expressing miR-324-5p or miR-338-5p miRNAs displayed reduced ability to induce 
the surface expression as well as total protein levels of PD-L1 on M. bovis BCG infection (Fig. 6f,g). Together, 
these results highlight a dichotomous role for M. bovis BCG-induced SHH signaling in DCs during expression 
of COX-2 and PD-L1.
NOTCH1 signaling-dependent PI3K-mTOR-NF-κB axis regulates the Th1 responses. After 
establishing the role for SHH signaling, the other identified signaling pathway (Fig. 1a,b) in DCs that affected 
the Treg expansion, NOTCH signaling, was analyzed. NOTCH1 signaling activation in DCs-infected with myco-
bacteria was assessed using transcript analysis of HES1, NOTCH1, JAG1 and JAG2 and generation of NICD. 
Elevated levels of HES1 and JAG2 transcripts and NICD marked the activation of NOTCH1 signaling on M. 
tuberculosis or M. bovis BCG infection (Fig. 7a,b). Exploring the role for other NOTCH receptor, it was found 
that while no increase in the transcripts of NOTCH2-4 was observed on M. bovis BCG stimulation, intracellular 
domain of NOTCH2 and NOTCH4 were induced on mycobacterial infection (Fig. 7c,d). However, we chose 
to analyze the function of NOTCH1 signaling in the current study as its activation was found comparatively 
more robust. While inhibition of PI3K-mTOR-NF-κ B axis did not alter the M. bovis BCG-induced NICD gen-
eration (Fig. 7e), pharmacological intervention of NOTCH1 signaling using GSI significantly abrogated the 
M. bovis BCG-mediated activation of PI3K-mTOR-NF-κ B pathway suggesting that NOTCH1 pathway regu-
lates the PI3K-mTOR-NF-κ B signaling cascade (Fig. 7f). In line with this observation, NOTCH1-responsive 
PI3K-mTOR-NF-κ B axis was found essential for generation of M. bovis BCG-induced inflammatory cytokines 
like IL-6, TNF-α and IL-12 despite for the fact that no change in the infection-induced DC maturation was 
observed when PI3K-mTOR-NF-κ B pathway was inhibited (Fig. 7g).
Counter-regulation of SHH and NOTCH1 signaling during M. bovis BCG infection. Previously, 
we found that NOTCH1 signaling negatively regulated the M. bovis BCG-mediated CD4+CD25+FoxP3+ Treg 
expansion (Fig. 1a,b). In accordance with this observation, DCs treated with GSI exhibited increased expression 
of PD-L1 on M. bovis BCG infection (Fig. 8a,b). This suggests that M. bovis BCG-induced NOTCH1 signaling 
negatively regulates PD-L1 expression to regulate Treg expansion. On the other hand, DCs treated with cyclopa-
mine displayed enhanced expression of JAG2 transcript (Fig. 8c) and increased NICD formation (Fig. 8d,e). 
Figure 2. M. bovis BCG-induced proinflammatory responses are moderately NOTCH dependent and 
suppressed by SHH. DCs were cultured with GM-CSF and IL-4 and left untreated (Med) or infected with 
M. bovis BCG alone or after 1 h pretreatment with the indicated inhibitors for 24 h. (mean ± SEM, n = 6–10) 
(a) Surface expression of maturation markers CD83, HLA-DR, CD40, CD86 and CD80 were examined by 
flow cytometry. Data is represented as % positive cells or MFI. (b) Cell-free supernatants from the above-
said experiment were assessed for secretion of IL-6, TNF-α , IL-12p70 by cytokine bead array (mean ± SEM, 
n = 5). Med, Medium. *P < 0.05; **P < 0.005; ***P < 0.001 (one-way ANOVA followed by Turkey’s multiple-
comparisons test).
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Together, these results indicate a counter-balance between the effects of infection-induced NOTCH1 and SHH 
signaling cascades to regulate CD4+CD25+FoxP3+ Treg expansion.
Discussion
Induction and expansion of an inhibitory CD25+FoxP3+ Treg population reckons as one of the immune eva-
sion strategies that mycobacteria employ to combat the protective immune responses5,9,15,16. In the current 
investigation, we found novels roles for SHH and NOTCH1 pathways in modulating M. bovis BCG-induced 
Treg expansion. We attribute the current observation to Treg expansion and not Treg induction as co-culture 
experiments with naïve CD4+ T did not show significant change in Treg population on mycobacterial infec-
tion (data not shown).While no previous reports were available implicating SHH signaling regulating Treg 
functions, multiple studies in mice and humans have identified NOTCH signaling to modulate Treg population. 
Overexpression of JAG1 signaling in DCs induced a regulatory phenotype in CD4+ T cells in both humans and 
mice34,35. However, direct role of JAG1 assisting the differentiation of naive CD4+ T to Tregs is not established, 
underscoring the differential functions of JAG1 in regulating Treg generation in humans and mice36. In another 
investigation, NOTCH1 signaling was found to promote TGF-β -mediated Treg functions in both humans and 
mice26. On the contrary, DLL4-mediated NOTCH signaling inhibits TGF-β -mediated Treg development and 
JNK-responsive STAT5 activation, a requisite for FoxP3 expression and maintenance25,37. In line with latter obser-
vation, mycobacteria-responsive activation of NOTCH1-JAG2 axis in DCs was found to suppress CD25+FoxP3+ 
Treg population. Supporting our observation, while JAG2 was found to expand Tregs during graft rejection in 
mice38, elevated JAG2 levels in hematopoietic progenitor cells was required for Treg expansion in mice to suppress 
T cell-mediated diseases39. Significant contribution of the WNT pathway in Treg expansion was not observed. 
However, previous reports suggest both positive and negative regulation of Treg functions by the canonical WNT 
signaling pathway. While inhibition of β -CATENIN in DCs comprised their ability to induce Tregs27, WNT sig-
naling activation inhibited the transcriptional activity of FoxP3 in T cells28.
Figure 3. PI3K-mTOR-NF-κB pathway mediates M. bovis BCG-induced SHH signaling and Treg 
expansion. (a,b) Five-day-old differentiated immature DCs were infected with 1:10 MOI of M. bovis BCG or 
M. tuberculosis H37Ra for 6 h. Transcript (a) and protein (b) levels of various SHH signaling markers were 
determined using quantitative real time RT-PCR and immunoblotting respectively. (c,d) Expression analysis 
of SHH signaling markers in immature DCs pretreated with the indicated pharmacological inhibitors for 1 h 
prior to 6 h infection with M. bovis BCG. (e) DCs infected with M. bovis BCG alone or after pretreatment of 
LY294002 (PI3K inhibitor), Rapamycin (mTOR inhibitor) or BAY 11-7085 (NF-κ B inhibitor) were co-cultured 
with autologous CD4+ T cells. Percentage of CD4+CD25+FoxP3+ T cells (mean ± SEM, n = 4) were analyzed 
by flow cytometry. All RT-PCR data represents the mean ± SEM from at least 3 independent experiments and 
all blots are representative of 3 independent experiments. Images have been cropped for presentation; full-size 
blot is shown in Supplementary Fig. S1. Med, Medium. *P < 0.05; **P < 0.005; ***P < 0.001 (one-way ANOVA 
followed by Turkey’s multiple-comparisons test).
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M. bovis BCG-induced NOTCH1-PI3K-mTOR-NF-κ B signaling in DCs was also found to promote inflam-
matory cytokines like IL-1β , IL-6, TNF-α and IL-12. Multiple investigations in both humans and mice have 
subscribed a NOTCH signaling ligand-specific T cell differentiation40: Th141–43, Th244–46 and Th1747,48. However, 
in the current investigation, mycobacterial infection of human DCs induced NOTCH1 signaling to program 
the cells towards pro-inflammatory in nature. This observation is in accordance with our previous report that 
suggested a function of a mycobacterial immunodominant protein, Rv0754, in regulating a NOTCH1-PI3K 
pathway-dependent pro-inflammatory environment to subvert CTLA-4- and TGF-β -induced suppression of DC 
maturation22. Interestingly, though infection-induced signaling pathways regulated the DC functions in terms of 
modulating the specific cytokines and T cell phenotype, no apparent role for these identified pathways was found 
for DC maturation.
To identify the molecular mechanism that mediates SHH and NOTCH signaling-responsive T cell pheno-
type during mycobacterial infection, we chose to analyze the contributions of PD-L1, PD-L2 and PGE2. The 
co-stimulatory molecules on the APCs, PD-L1 and PD-L2 signal to the PD-1 on the T cells to orchestrate a 
Treg differentiation and expansion49. Formation of the PD-L1 and PD-1 ligand-receptor complex triggers the 
SHP1/2 activation that suppresses the STAT1 activity, thereby abrogating IFN-γ -mediated responses. STAT1 is 
Figure 4. M. bovis BCG-induced PD-L1 and COX-2 are SHH signaling dependent. (a,b) Quantitative real 
time RT-PCR for expression analysis of PD-L1, PD-L2, PTGS2/COX-2 and ELISA from cell-free supernatants to 
estimate the secretion of PGE2 on (a) infection of immature DCs with M. bovis BCG or M. tuberculosis H37Ra for 
12 h or (b) infection of indicated pharmacological inhibitor treated immature DCs with M. bovis BCG for 12 h.  
(c) DCs were cultured in GM-CSF and IL-4 alone (Med) or with pharmacological inhibitor followed by  
M. bovis BCG as indicated for 24 h. Surface expression of PD-L1 as % positive cells was analyzed by flow 
cytometry (mean ± SEM, n = 8). (d,e) DCs were treated as explained above. Immunoblotting for COX-2 from 
total cell lysate (d) and ELISA for measuring PGE2 in the cell-free supernatant (e). (f–i) Immature human DCs 
were transiently transfected with NT or SHH siRNA. 48 h post transfection, cells were infected with M. bovis BCG 
for 24 h to assess the surface expression of PD-L1 by flow cytometry (mean ± SEM, n = 4) (f) or 12 h to estimate 
COX-2 protein by immunoblotting (g) and PGE2 in the cell-free supernatant by ELISA (h). Validation of SHH 
siRNA was performed by immunoblotting for SHH in the siRNA-transfected DCs (i). All RT-PCR and ELISA 
data represents the mean ± SEM from at least 3 independent experiments and all blots are representative of 3 
independent experiments. Images have been cropped for presentation; full-size blot is shown in Supplementary 
Fig. S1. Med, Medium; NT, Non-targeting. *P < 0.05; **P < 0.005; ***P < 0.001 (one-way ANOVA followed by 
Turkey’s multiple-comparisons test).
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otherwise known to inhibit FoxP3 expression50. Importantly, reports suggest that induced expression of PD-L1 
in human DCs is necessary for mycobacteria-induced Treg expansion15,16. However, PD-L1 KO and PD-1 KO 
mice strangely displayed exacerbated tuberculosis disease with excessive inflammatory responses and increased 
susceptibility to infection underscoring the crucial role for PD-L1 signaling during mycobacterial infection14,51. 
Interestingly, inhibition of PD-L1 in DCs also promoted mycobacteria-induced IFN-γ production in T cells52. Of 
note, COX-2 catalyzed PGE2 serves as a cue for Treg expansion and functions53,54. PGE2-EP signaling is known to 
aid in FoxP3 expression55. Importantly, in humans, mycobacterial infection triggers PGE2-dependent expansion 
of CD25+FoxP3+ Tregs17. In agreement with all these observations, our results revealed that SHH-dependent 
expression of PD-L1 and COX-2-PGE2 during mycobacterial infection induces the Treg expansion. It was also 
noted that there was synergistic effect of PD-L1 and COX-2 in mediating mycobacteria-induced Treg expansion. 
In fact, upon inhibition of both PD-L1 and COX-2, the Treg frequency reached close to medium control condi-
tions. Interestingly, a recent report showed similar synergistic effects of COX and PD-1 for eradication of tumors 
and its usefulness as adjuvants for immune-based therapies56. Further, while expression of COX-2 was a tran-
scriptional regulation by SHH signaling, post-transcriptional regulation of PD-L1 by SHH signaling-regulated 
miRNAs was observed.
Based on available information on genome-wide miRNA profiling in tuberculosis patients vs healthy indi-
viduals20,32,57,58 and ex-vivo infection studies33, a panel of miRNAs that were downregulated on mycobacterial 
infection and served as putative miRNAs that target PD-L1 were chosen for the study. MiR-155 was utilized as 
a positive control as it is not only known to be induced to several manifolds during mycobacterial infection, but 
also associated with maturation of DCs59,60. Among the tested miRNAs, miR-324-5p and miR-338-5p were iden-
tified as the bonafide miRNAs that target PD-L1 in a SHH-dependent manner and hence, downregulated during 
mycobacterial infection. However, the mechanism of SHH-mediated transcriptional regulation of miR-324-5p 
and miR-338-5p needs to be studied further.
Mycobacteria harbors numerous antigens that are recognized by several pattern recognition receptors; TLR2 
being the dominant one. Various studies, including ours, have suggested that mycobacteria and its antigens 
Figure 5. PD-L1 and COX-2 mediate M. bovis BCG-induced Treg expansion. (a) Inhibition of either 
PD-L1 or COX-2, partially inhibit the BCG-induced Treg expansion. γ -irradiated BCG-stimulated DCs 
were incubated with anti-PD-L1 blocking antibody or isotype antibody (upper panel). Alternatively, DCs 
were pretreated with DMSO or NS-398 (COX-2 inhibitor) before stimulation with BCG (lower panel). After 
extensive wash, DCs were co-cultured with autologous CD4+ T cells for five days. Representative dot-plots 
showing frequency of CD4+CD25+FoxP3+ Tregs were presented. The Treg response induced by DCs cultured in 
medium alone is represented by ‘Med’. (b,c) Inhibition of both PD-L1 and COX-2 in DCs significantly suppress 
the ability of BCG to expand Tregs. DCs were pretreated with DMSO or NS-398 before stimulation with BCG. 
After extensive washing, these DCs were incubated with anti-PD-L1 blocking antibody or isotype antibody 
and co-cultured with autologous CD4+ T cells for five days. CD4+CD25+FoxP3+ Tregs were analyzed by flow 
cytometry. Representative dot-plots showing frequency of CD4+CD25+FoxP3+ Tregs were presented (b).  
(c) Percentage of CD4+CD25+FoxP3+ cells in the DC-CD4+ T cell co-cultures (mean ± SEM, n = 5). *P < 0.05 
(one-way ANOVA followed by Holm-Sidak’s multiple comparisons test).
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induce TLR2 signaling in both macrophages and DCs16,18,19,21–23,57,61. Importantly, many of these previous 
studies have implicated that mycobacteria-induced activation of NOTCH in both macrophages18,62 and DCs22 
and mycobacteria-induced activation of SHH pathways in macrophages20,21 were TLR2-dependent. Further, 
while current and previous results18,22 suggest that mycobacteria-induced NOTCH1 signals the activation of 
PI3K-mTOR-NF-κ B axis, current and a previous study20 also suggests that mycobacteria-induced SHH signaling 
is PI3K-mTOR-NF-κ B dependent. Keeping these results in mind, TLR2-dependent activation of NOTCH1 sign-
aling during mycobacterial infection could play a dominant role in DCs. However, we have not assessed the role 
of TLR2 in the current study.
In summary, establishing novel roles for SHH and NOTCH1 signaling pathways, we found 
mycobacteria-activated SHH signaling induces PD-L1 and COX-2-PGE2 to mediate the expansion of 
CD4+CD25+FoxP3+ Tregs whereas infection-induced NOTCH1 signaling was found to suppress the Treg expan-
sion (Fig. 8f). Thus, mycobacteria modulate the host signaling pathways and molecular regulators in DCs to 
determine the functional outcome of the immune responses including Tregs expansion.
Methods
Antibodies. Fluorescein isothiocyanate (FITC)-conjugated monoclonal antibodies (mAbs) to CD86, CD1a, 
PD-L1 (CD274), IFN-γ (all anti-human), phycoerythrin (PE)-conjugated mAbs to CD80, CD83 and CD25, 
APC-conjugated HLA-DR (all anti-human), anti-human Alexa Fluor 700-CD4 were from BD Biosciences, and 
PE-conjugated mAb to anti-human CD40 was from Becton Dickinson. Human Foxp3-APC, anti-PD-L1 and 
isotype control were from eBioscience. CD14 magnetic beads, T cell isolation kit II, GM-CSF and IL-4 were from 
Figure 6. Bi-functional role of SHH signaling to regulate PD-L1 and COX-2 expression. (a) The recruitment 
of GLI1 at human PTGS2 and PD-L1 promoter upon infection with M. bovis BCG for 12 h in immature DCs was 
evaluated by ChIP assay. (b,c) DCs were infected with M. bovis BCG or M. tuberculosis H37Ra alone (b) or with 
pharmacological inhibitors of SHH pathway (c) and quantitative real time RT-PCR analysis was performed on 
total RNA isolated using indicated miRNA-specific primers. (d) Putative miR-324-5p and miR-338-5p binding 
sites in the 3′UTR of PD-L1. (e) THP-1 cells were transfected with WT PD-L1 3′UTR or miR-324-5pΔ miR-338-
5pΔ PD-L1 3′UTR constructs with miR-324-5p or miR-338-5p mimics as indicated. Transfected THP-1 cells 
were further stimulated with M. bovis BCG as indicated and luciferase assay was performed.  
(f,g) DCs transfected with control or miR-324-5p and miR-338-5p mimics were infected with M. bovis BCG 
for 24 h (f) or 18 h (g) as indicated. While surface expression of PD-L1 was evaluated by flow cytometry 
(mean ± SEM, n = 3) (f), protein levels of PD-L1 in the total cell lysate was assessed by immunoblotting  
(g). All RT-PCR and luciferase data represents the mean ± SEM from 3 independent experiments. Images have 
been cropped for presentation; full-size blot is shown in Supplementary Fig. S1. Med, Medium; NC, Negative 
control. *P < 0.05; **P < 0.005; ***P < 0.001 (Student’s t-test for Panel a, one-way ANOVA followed by Turkey’s 
multiple-comparisons test for others).
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Miltenyi Biotec. Anti-β -ACTIN and anti-PGE2 antibodies were purchased from Sigma-Aldrich. Anti-SHH, anti-
GLI1, anti-NUMB, anti-Ser9 phospho-GSK-3β , anti-NICD (Cleaved Notch1), anti-Ser2448 phospho mTOR, 
anti-Tyr458 phospho p85 and anti-Ser536 phospho NF-κB p65 were purchased from Cell Signaling Technology. 
Anti-COX-2 was from Calbiochem. Anti-Notch 2 intracellular domain and anti-Notch 4 -C-terminal anti-
bodies were from Abcam. HRP conjugated anti-rabbit IgG and anti-mouse IgG was obtained from Jackson 
ImmunoResearch.
Generation of Human DCs. Human Peripheral blood mononuclear cells (PBMC) were isolated from buffy 
coats of the healthy blood donors purchased from Centre Necker-Cabanel, Etablissement Français du Sang, Paris, 
France. Ethical committee permission was obtained for the use of buffy bags of healthy donors (N°12/EFS/079). 
All samples were analyzed anonymously. Circulating monocytes were isolated from these PBMCs using CD14 
magnetic beads. The purity was more than 98%. Monocytes were cultured in RMPI-1640 medium containing 
Figure 7. M. bovis BCG-induced NOTCH1 signaling in DCs regulates PI3K-mTOR-NF-κB pathway.  
(a) Quantitative real time RT-PCR for assessing NOTCH1 signaling markers, HES1, NOTCH1, JAG1 and JAG2 
on infection of immature DCs with M. bovis BCG or M. tuberculosis H37Ra for 6 h. (b) Activation of NOTCH1 
signaling was determined by immunoblotting for NICD in DCs infected with M. bovis BCG or M. tuberculosis 
H37Ra. (c,d) Transcript (c) and intracellular domain (d) of NOTCH2-4 on M. bovis BCG stimulation was 
analyzed by quantitative real time RT-PCR (c) or immunoblotting (d). (e) NOTCH1 signaling activation was 
assessed by immunoblotting for NICD in DCs pretreated with the indicated pharmacological inhibitors and 
infected with M. bovis BCG. (f) Immunoblotting for evaluating PI3K-mTOR-NF-κ B pathway activation using 
DCs infected with M. bovis BCG with or without GSI (NOTCH signaling inhibitor). (g) DCs were cultured 
with GM-CSF and IL-4 and left untreated (Med) or infected with M. bovis BCG alone or after 1 h pretreatment 
with the indicated inhibitors for 24 h. Surface expression of maturation markers CD83, HLA-DR, CD40, CD86 
and CD80 were examined by flow cytometry (mean ± SEM, n = 7–10). Data is represented as % positive cells 
or MFI ((g), top panels). Cell-free supernatants from the above-said experiment were assessed for secretion 
of IL-6, TNF-α , IL-12p70 by cytokine bead array ((g), lower panels) (mean ± SEM, n = 5–7). All RT-PCR 
data represents the mean ± SEM from at least 3 independent experiments and all blots are representative of 3 
independent experiments. Images have been cropped for presentation; full-size blot is shown in Supplementary 
Fig. S2. Med, Medium. *P < 0.05; **P < 0.005; ***P < 0.001 (one-way ANOVA followed by Turkey’s multiple-
comparisons test).
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10% FCS in the presence of GM-CSF (1000 IU/106 cells) and IL-4 (500 IU/106 cells) for 5 days to obtain immature 
DCs and used for subsequent experiments.
Stimulation of DCs with mycobacteria. 0.5 × 106 immature DCs (FACS, Co-culture experiments) or 
106 immature DCs (Immunoblotting, RNA isolation, transfections experiments) or 2 × 106 immature DCs (ChIP 
experiments) were washed and infected with 1:10 multiplicity of infection (MOI) of M. bovis BCG or M. tuber-
culosis H37Ra for indicated time in the presence of GM-CSF and IL-4. Supernatants were collected for analyz-
ing cytokines and cells were utilized for further indicated assays. M. bovis BCG Pasteur 1173P2 was obtained 
from Pasteur Institute, Paris, France and M. tuberculosis H37Ra was kind research gift from Dr. P. Ajitkumar, 
IISc, India. Mycobacteria were grown in Middlebrook 7H9 broth to mid-log phase and then aliquoted, following 
which it was stored at − 70 °C. Representative vials were thawed and the mycobacterial cells’ viability was then 
assessed by plating on Middlebrook 7H10 agar plates.
Treatment with pharmacological reagents. Cells were treated with the given inhibitor (from 
Calbiochem) for 1 h before experimental treatments at following concentrations: Cyclopamine (15 μM); IWP-2 
(5 μM); GSI (750 nM); LY294002 (10 μM); Rapamycin (200 nM); BAY 11-7085 (5 μM); NS-398 (25 μM). DMSO 
at 0.1% concentration was used as the vehicle control. In all experiments involving pharmacological reagents, a 
tested concentration was used after careful titration experiments assessing the viability of the DCs using the MTT 
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.
Transient transfection studies. Transient transfection of immature DCs with 100 nM siRNA or 150 nM 
miRNA mimics were carried out utilizing Oligofectamine reagent (Life Technologies). SHH, non-targeting siRNA 
and siGLO Lamin A/C were obtained from Dharmacon as siGENOME™ SMARTpool reagents, which contain 
a pool of four different double-stranded RNA oligonucleotides. MiR-324-5p, miR-338-5p mimics and negative 
control mimics were purchased from Ambion (Life Technologies). Transfection efficiency was found to be more 
than 50% in all the experiments as determined by counting the number of siGLO Lamin A/C positive cells in a 
Figure 8. Counter-regulation of NOTCH1 and SHH pathway functions during M. bovis BCG infection of 
DCs. (a,b) Transcript (a) and surface (b) expression of PD-L1 in DCs infected with M. bovis BCG alone or after 
1 h pretreatment of GSI by quantitative real time RT-PCR and flow cytometry (mean ± SEM, n = 7) respectively. 
(c–e) Immature DCs were pretreated with SHH signaling inhibitors and infected with M. bovis BCG for 6 h. 
NOTCH1 signaling markers, NOTCH1, JAG1 and JAG2 transcripts were analyzed using quantitative real time 
RT-PCR (c), NICD by immunoblotting (d) and densitometric analysis of panel D (e). (f) Model: schematic 
representation of the obtained results. All RT-PCR and densitometry data represents the mean ± SEM from at 
least 3 independent experiments and all blots are representative of 3 independent experiments. Images have 
been cropped for presentation; full-size blot is shown in Supplementary Fig. S2. Med, Medium. *P < 0.05; 
**P < 0.005; ***P < 0.001 (one-way ANOVA followed by Turkey’s multiple-comparisons test).
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microscopic field using fluorescent microscope. 48 h post siRNAs transfection or 24 h post miRNAs transfection, 
the cells were treated or infected as indicated and processed for analysis.
RNA isolation and quantitative real time RT-PCR. DCs were treated or infected as indicated 
and total RNA from the cells was isolated by TRI reagent (Sigma-Aldrich). 2 μg of total RNA was con-
verted into cDNA using First strand cDNA synthesis kit (Invitrogen). Quantitative real time RT-PCR 
was performed using SYBR Green PCR mixture (KAPA Biosystems) for quantification of the target gene 
expression. All the experiments were repeated at least three times independently to ensure the reproduc-
ibility of the results. GAPDH was used as internal control. The primers used for PCR amplification are: 
GAPDH forward 5′-ggagcgagatccctccaaaat-3′, GAPDH reverse 5′-ggctgttgtcatacttctcatgg-3′; PD-L1 forward 
5 ′-ggacaagcagtgaccatcaag-3 ′ ,  PD-L1  reverse 5 ′-cccagaattaccaagtgagtcct-3 ′ ;  PD-L2  for ward 
5′-accgtgaaagagccactttg-3′, PD-L2 reverse 5′-gcgaccccatagatgattatgc-3′; PTGS2 forward 5′-ggtggagaagtgggttttca-3′, 
PTGS2 reverse 5′-gactcctttctccgcaacag-3′; SHH forward 5′-ctcgctgctggtatgctcg-3′, SHH reverse 
5′-atcgctcggagtttctggaga-3′; GLI1 forward 5′-agcgtgagcctgaatctgtg-3′, GLI1 reverse 5′-cagcatgtactgggctttgaa-3′; 
PTCH1 forward 5′-ccagaaagtatatgcactggca-3′; PTCH1 reverse 5′-gtgctcgtacatttgcttggg-3′; HES1 forward 
5′-acacgacaccggataaaccaa-3′, HES1 reverse 5′-gccgccagctatctttcttca-3′; NOTCH1 forward 5′-gaggcgtggcagactatgc-3′, 
NOTCH1 reverse 5′-cttgtactccgtcagcgtga-3′; JAG1 forward 5′-tcgggtcagttcgagttgga-3′, JAG1 reverse 
5′-aggcacactttgaagtatgtgtc-3′; JAG2 forward 5′-tgggactgggacaacgatac-3′, JAG2 reverse 5′-agtggcgctgtagtagttctc-3′; 
NOTCH2 forward 5′-tattgatgactgccctaaccaca-3′, NOTCH2 reverse 5′-atagcctccattgcggttgg-3′; NOTCH3 
forward 5′-aagtcggggcacagtttctc-3′, NOTCH3 reverse 5′-ctcccactcaccgatctgg-3′; NOTCH4 forward 
5′-gatgggctggacacctacac-3′, NOTCH4 reverse 5′-cacacgcagtgaaagctacca-3′.
Quantification of miRNA expression. For detection of miRNAs, total RNA was isolated from infected 
or treated DCs using the TRI reagent. Quantitative real time RT-PCR for miR-155, miR-15b, miR-324-5p, miR-
338-5p and miR-425-5p was performed using TaqMan miRNA assays (Ambion) as per manufacturer’s instruc-
tions. U6 snRNA was used for normalization.
Immunoblotting. Infected or treated DCs were lysed in RIPA buffer constituting 50 mM Tris-HCl (pH 7.4), 
1% NP-40, 0.25% Sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 μg/ml of each aprotinin, 
leupeptin, pepstatin, 1 mM Na3VO4 and 1 mM NaF. Equal amount of protein from each cell lysate was resolved 
on a 12% SDS-polyacrylamide gel and transferred to polyvinylidene difluoride membranes (PVDF) (Millipore) 
by the semi-dry transfer (Bio-Rad) method. Nonspecific binding was blocked with 5% nonfat dry milk powder in 
TBST [20 mM Tris-HCl (pH 7.4), 137 mM NaCl, and 0.1% Tween 20] for 60 min. The blots were incubated over-
night at 4 °C with primary antibody followed by incubation with anti-rabbit-HRP or anti-mouse-HRP secondary 
antibody in 5% BSA for 2 h. After washing in TBST, the immunoblots were developed with enhanced chemilu-
minescence detection system (Perkin Elmer) as per manufacturer’s instructions. β -ACTIN was used as loading 
control. For probing another protein in the same region of the PVDF membrane, the blots were stripped in the 
stripping buffer [62.5 mM Tris-HCl (pH 6.8), 2% SDS and 0.7% β -mercaptoethanol] at 60 °C on a shaker, blocked 
with 5% nonfat dry milk powder and probed with antibodies as mentioned above.
DC:CD4+ T cell co-cultures. Autologous CD4+ T cells were obtained using T cell isolation kit II. The treated 
DCs were co-cultured with CD4+ T cells at 1:10 for 5 days. Cell-free culture supernatants were collected for the 
analysis of T cell cytokines. Cells were treated with PMA-Ionomycin and Golgistop for 5 h. Following this, the T 
cells were processed for staining with fluorchrome-conjugated mAbs for flow cytometry.
γ-irradiated BCG-stimulated DC:CD4+ T cell co-culture. Immature DCs treated with DMSO or 25 μM 
NS-398 for 1 h were stimulated with 20 μg/ml γ -irradiated BCG (Strain AF 2122/97 (ATCC® BAA-935™ ) obtained 
through BEI Resources, NIAID, NIH) for 24 h. Post stimulation, DCs were thoroughly washed with RPMI, counted 
and blocked with isotype control or anti-PD-L1 (10 μg/ml) for 1 h. DCs were then co-cultured with autologous 
CD4+ T cells at 1:10 ratio for 5 days. On day 0 and day 3 of the co-culture, 25 μM NS-398 was added for efficient 
COX-2 inhibition. T cells were processed for staining with fluorchrome-conjugated mAbs for flow cytometry.
Flow cytometry. Surface staining of CD1a, HLA-DR, CD40, CD83, CD80 and CD86 on DCs was per-
formed using fluorochrome-conjugated mAbs. T cells were surface-labeled with CD25- and CD4-specific 
fluorochrome-conjugated mAbs and then washed, fixed, permeabilized for intracellular staining of FoxP3. Cells 
were further processed for flow cytometry wherein 5000 gated events were recorded for each sample acquired in 
BD LSR II or BD FACSCanto II and the data was analyzed using FACSDiva™ software (BD Biosciences).
Cytokine analysis. Cytokines were quantified in the cell-free culture supernatants using BD™ Cytometric 
Bead Array (CBA) human inflammatory cytokine kits (IL-1β , CXCL8/IL-8, TNF-α , IL-6, IL-10 and IL-12p70) 
and human Th1/Th2 cytokine kits (IL-2, IL-4, IL-5, IL-10, TNF-α and IFN-γ ) (BD Biosciences). The data were 
analyzed using FCAP Array™ software (BD Biosciences).
Enzyme immunoassay for PGE2. Enzyme immunoassays for quantitation of PGE2 were carried out in 
96-well microtiter plates (Nunc) using culture supernatant. ELISA plates were incubated with culture supernatant 
overnight at 4 °C followed by three washes with 1X PBST. After blocking with 1% BSA for 1 h at 37 °C, wells were 
incubated with anti-PGE2 antibod y for 6 h at 37 °C followed by washing with 1X PBST. The plates were further 
incubated with HRP conjugated anti-rabbit secondary antibody for 2 h at 37 °C. The assay was developed with 
3,3′,5,5′-tetramethylbenzidine (Sigma-Aldrich). The absorbance values were measured at 450 nm by using ELISA 
reader (Molecular Devices).
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Chromatin Immunoprecipitation (ChIP) Assay. ChIP assays were carried out using a protocol provided 
by Upstate Biotechnology and Sigma-Adrich with certain modifications. Briefly, DCs were fixed with 1.42% for-
maldehyde for 15 min at room temperature followed by inactivation of formaldehyde with addition of 125 mM 
glycine. Nuclei were lysed in 0.1% SDS lysis buffer [50 mM Tris-HCl (pH 8.0), 200 mM NaCl, 10 mM HEPES 
(pH 6.5), 0.1% SDS, 10 mM EDTA, 0.5 mM EGTA, 1 mM PMSF, 1 μg/ml of each aprotinin, leupeptin, pepstatin, 
1 mM Na3VO4 and 1 mM NaF]. Chromatin was sheared using Bioruptor Plus (Diagenode) at high power for 40 
rounds of 30 sec pulse ON/45 sec OFF. Chromatin extracts containing DNA fragments with an average size of 
500 bp were immunoprecipitated using specific antibodies or rabbit preimmune sera according to the experi-
ment complexed with Protein A agarose beads (Bangalore Genei). Immunoprecipitated complexes were sequen-
tially washed [Wash Buffer A: 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% 
Sodium deoxycholate, 0.1% SDS and protease/phosphatase inhibitors; Wash Buffer B: 50 mM Tris-HCl (pH 8.0), 
1 mM EDTA, 250 mM LiCl, 0.5% NP-40, 0.5% Sodium deoxycholate and protease/phosphatase inhibitors; TE: 
10 mM Tris-HCl (pH 8.0), 1 mM EDTA] and eluted in elution buffer [1% SDS, 0.1 M NaHCO3]. After treating the 
eluted samples with RNase A and Proteinase K, DNA was precipitated using phenol-chloroform-ethanol method. 
Purified DNA was analyzed by quantitative real time RT-PCR. All values in the test samples were normalized 
to amplification of the specific gene in Input and IgG pull down and represented as fold enrichment. All ChIP 
experiments were repeated at least three times and the primers utilized for GLI1 binding at PTGS2 promoter are 
forward 5′-aaattgcgtaagcccggtggg-3′, reverse 5′-gacatctggcggaaacctgtgc-3′ and at PD-L1 promoter are forward 
5′-caggcacggtggctcaagcct-3′, reverse 5′-tctgccaccctaaggattaaggctgcgg-3′.
PD-L1 3′UTR WT/mutant generation and luciferase assay. The 3′UTR of PD-L1 was PCR ampli-
fied and cloned into pmirGLO vector using the restriction enzymes SacI and XbaI. Primer pairs used: WT 
PD-L1 3′UTR forward 5′-cgagctcgcattggaacttctgatcttc-3′, reverse 5′-gctctagagttatagaggagaccaagcac-3′. The 
miR-324-5p and miR-338-5p binding sites were mutated in PD-L1 3′UTR by nucleotide replacements through 
site-directed mutagenesis using the megaprimer inverse PCR method. The forward primer comprised the desired 
mutation and respective reverse primer was used to generate megaprimers. Primer pairs used: miR-324-5p 
megaprimer forward 5′-gcccgtaaagcataggcaat-3′, reverse 5′-cgtcgatgagcccctcagg-3′; miR-338-5p megaprimer 
forward 5′-tgaagatgcgccacagtagatgttac-3′, reverse 5′-gttatagaggagaccaagcac-3′. The miR-324-5p megaprimer was 
used to amplify the WT PD-L1 3′UTR plasmid to generate miR-324-5pΔ PD-L1 3′UTR plasmid. The double 
mutant plasmid was generated utilizing a megaprimer mutant for miR-338-5p-binding sites on the miR-324-
5pΔ mutant PD-L1 plasmid background. THP-1, human monocytic cell line obtained from the National Center 
for Cell Sciences, Pune, India, was used for the transfection studies. Cells were cultured in DMEM (Gibco-Life 
Technologies) containing 10% FBS (Gibco-Life Technologies). Transient transfection of THP-1 cells with 3′UTR 
constructs, β -Galactosidase construct and the miRNA mimics were performed as indicated using low m.w. pol-
yethylenimine (Sigma-Aldrich). After 48 h of transfection and desired stimulation, cells were lysed in Reporter 
lysis buffer (Promega) and assayed for luciferase activity using Luciferase Assay Reagent (Promega) as per the 
manufacturer’s instructions. The results were normalized for transfection efficiencies measured by β -galactosidase 
activity. O-nitrophenol β -D-galactopyranoside (HiMedia) was utilized for the β -galactosidase assay.
Statistical analysis. Levels of significance for comparison between samples were determined by the 
Student’s t test distribution and one-way ANOVA. The data in the graphs are expressed as the mean ± S.E for 
values from 3 independent experiments and P values < 0.05 were defined as significant. Graphpad Prism 5.0 
software (Graphpad software) was used for all the statistical analysis.
References
1. Sakaguchi, S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. 
Annu Rev Immunol 22, 531–562 (2004).
2. Sakaguchi, S., Miyara, M., Costantino, C. M. & Hafler, D. A. FOXP3+ regulatory T cells in the human immune system. Nat Rev 
Immunol 10, 490–500 (2010).
3. Rouse, B. T. & Suvas, S. Regulatory cells and infectious agents: detentes cordiale and contraire. J Immunol 173, 2211–2215 (2004).
4. Mills, K. H. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4, 841–855 (2004).
5. Kursar, M. et al. Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 178, 
2661–2665 (2007).
6. Scott-Browne, J. P. et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204, 
2159–2169 (2007).
7. Shafiani, S. et al. Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in 
response to Interleukin-12. Immunity 38, 1261–1270 (2013).
8. Mahan, C. S., Thomas, J. J., Boom, W. H. & Rojas, R. E. CD4+ CD25(high) Foxp3+ regulatory T cells downregulate human Vdelta2+ 
T-lymphocyte function triggered by anti-CD3 or phosphoantigen. Immunology 127, 398–407 (2009).
9. Li, L., Lao, S. H. & Wu, C. Y. Increased frequency of CD4(+ )CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma 
by CD4(+ ) T cells from TB patients. Tuberculosis (Edinb) 87, 526–534 (2007).
10. Quinn, K. M. et al. Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine 
production but does not affect pathogen load. Immunol Cell Biol 84, 467–474 (2006).
11. Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K. & Urdahl, K. B. Pathogen-specific regulatory T cells delay the arrival of 
effector T cells in the lung during early tuberculosis. J Exp Med 207, 1409–1420 (2010).
12. Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30, 
531–564 (2012).
13. Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat Rev Immunol 8, 523–532 (2008).
14. Barber, D. L., Mayer-Barber, K. D., Feng, C. G., Sharpe, A. H. & Sher, A. CD4 T cells promote rather than control tuberculosis in the 
absence of PD-1-mediated inhibition. J Immunol 186, 1598–1607 (2011).
15. Periasamy, S. et al. Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells 
upon stimulation With Mycobacterium tuberculosis. J Infect Dis 203, 1256–1263 (2011).
www.nature.com/scientificreports/
13Scientific RepoRts | 6:24193 | DOI: 10.1038/srep24193
16. Trinath, J., Maddur, M. S., Kaveri, S. V., Balaji, K. N. & Bayry, J. Mycobacterium tuberculosis promotes regulatory T-cell expansion 
via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells. J Infect Dis 205, 694–696 (2012).
17. Garg, A. et al. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human 
Mycobacterium tuberculosis infection. Eur J Immunol 38, 459–469 (2008).
18. Narayana, Y. & Balaji, K. N. NOTCH1 up-regulation and signaling involved in Mycobacterium bovis BCG-induced SOCS3 
expression in macrophages. J Biol Chem 283, 12501–12511 (2008).
19. Bansal, K., Trinath, J., Chakravortty, D., Patil, S. A. & Balaji, K. N. Pathogen-specific TLR2 protein activation programs macrophages 
to induce Wnt-beta-catenin signaling. J Biol Chem 286, 37032–37044 (2011).
20. Ghorpade, D. S. et al. Sonic hedgehog-dependent induction of microRNA 31 and microRNA 150 regulates Mycobacterium bovis 
BCG-driven toll-like receptor 2 signaling. Mol Cell Biol 33, 543–556 (2013).
21. Holla, S., Kurowska-Stolarska, M., Bayry, J. & Balaji, K. N. Selective inhibition of IFNG-induced autophagy by Mir155- and Mir31-
responsive WNT5A and SHH signaling. Autophagy 10, 311–330 (2014).
22. Ghorpade, D. S., Kaveri, S. V., Bayry, J. & Balaji, K. N. Cooperative regulation of NOTCH1 protein-phosphatidylinositol 3-kinase 
(PI3K) signaling by NOD1, NOD2, and TLR2 receptors renders enhanced refractoriness to transforming growth factor-beta (TGF-
beta)- or cytotoxic T-lymphocyte antigen 4 (CTLA-4)-mediated impairment of human dendritic cell maturation. J Biol Chem 286, 
31347–31360 (2011).
23. Bansal, K. et al. PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. 
J Immunol 184, 3495–3504 (2010).
24. Bansal, K. et al. Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of 
human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses. J Biol Chem 285, 
36511–36522 (2010).
25. Billiard, F. et al. Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice. J Exp Med 209, 
1011–1028 (2012).
26. Asano, N., Watanabe, T., Kitani, A., Fuss, I. J. & Strober, W. Notch1 signaling and regulatory T cell function. J Immunol 180, 
2796–2804 (2008).
27. Manicassamy, S. et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329, 
849–853 (2010).
28. van Loosdregt, J. et al. Canonical Wnt signaling negatively modulates regulatory T cell function. Immunity 39, 298–310 (2013).
29. Koyasu, S. The role of PI3K in immune cells. Nat Immunol 4, 313–319 (2003).
30. Koorella, C. et al. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in 
interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells. J Biol Chem 289, 7747–7762 (2014).
31. Varjosalo, M. & Taipale, J. Hedgehog: functions and mechanisms. Genes Dev 22, 2454–2472 (2008).
32. Fu, Y., Yi, Z., Wu, X., Li, J. & Xu, F. Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol 49, 
4246–4251 (2011).
33. Furci, L., Schena, E., Miotto, P. & Cirillo, D. M. Alteration of human macrophages microRNA expression profile upon infection with 
Mycobacterium tuberculosis. International Journal of Mycobacteriology 2, 128–134 (2013).
34. Hoyne, G. F. et al. Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral 
CD4(+ ) T cells. Int Immunol 12, 177–185 (2000).
35. Yvon, E. S. et al. Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood 102, 
3815–3821 (2003).
36. Tsukumo, S. & Yasutomo, K. Notch governing mature T cell differentiation. J Immunol 173, 7109–7113 (2004).
37. Bassil, R. et al. Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory 
T cell development. J Immunol 187, 2322–2328 (2011).
38. Riella, L. V. et al. Jagged2-signaling promotes IL-6-dependent transplant rejection. Eur J Immunol 43, 1449–1458 (2013).
39. Kared, H. et al. Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch 
signaling. Immunity 25, 823–834 (2006).
40. Yuan, J. S., Kousis, P. C., Suliman, S., Visan, I. & Guidos, C. J. Functions of notch signaling in the immune system: consensus and 
controversies. Annu Rev Immunol 28, 343–365 (2010).
41. Amsen, D. et al. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117, 
515–526 (2004).
42. Minter, L. M. et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch 
upregulation of Tbx21. Nat Immunol 6, 680–688 (2005).
43. Gentle, M. E., Rose, A., Bugeon, L. & Dallman, M. J. Noncanonical Notch signaling modulates cytokine responses of dendritic cells 
to inflammatory stimuli. J Immunol 189, 1274–1284 (2012).
44. Rutz, S. et al. Notch regulates IL-10 production by T helper 1 cells. Proc Natl Acad Sci USA 105, 3497–3502 (2008).
45. Tu, L. et al. Notch signaling is an important regulator of type 2 immunity. J Exp Med 202, 1037–1042 (2005).
46. Fang, T. C. et al. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27, 100–110 (2007).
47. Mukherjee, S., Schaller, M. A., Neupane, R., Kunkel, S. L. & Lukacs, N. W. Regulation of T cell activation by Notch ligand, DLL4, 
promotes IL-17 production and Rorc activation. J Immunol 182, 7381–7388 (2009).
48. Bugeon, L., Gardner, L. M., Rose, A., Gentle, M. & Dallman, M. J. Cutting edge: Notch signaling induces a distinct cytokine profile 
in dendritic cells that supports T cell-mediated regulation and IL-2-dependent IL-17 production. J Immunol 181, 8189–8193 (2008).
49. Francisco, L. M., Sage, P. T. & Sharpe, A. H. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236, 219–242 (2010).
50. Amarnath, S. et al. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med 3, 111ra120 (2011).
51. Lazar-Molnar, E. et al. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci 
USA 107, 13402–13407 (2010).
52. Stephen-Victor, E. et al. Inhibition of Programmed Death 1 Ligand 1 on Dendritic Cells Enhances Mycobacterium-Mediated 
Interferon gamma (IFN-gamma) Production Without Modulating the Frequencies of IFN-gamma-Producing CD4+ T Cells. J Infect 
Dis (2014).
53. Trinath, J. et al. Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent 
prostaglandin E2 in human dendritic cells. Blood 122, 1419–1427 (2013).
54. Baratelli, F. et al. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am J 
Transl Res 2, 356–367 (2010).
55. Baratelli, F. et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 
175, 1483–1490 (2005).
56. Zelenay, S. et al. Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity. Cell 162, 1257–1270 (2015).
57. Ghorpade, D. S., Leyland, R., Kurowska-Stolarska, M., Patil, S. A. & Balaji, K. N. MicroRNA-155 is required for Mycobacterium 
bovis BCG-mediated apoptosis of macrophages. Mol Cell Biol 32, 2239–2253 (2012).
58. Wang, C. et al. Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PLoS One 6, e25832 
(2011).
www.nature.com/scientificreports/
1 4Scientific RepoRts | 6:24193 | DOI: 10.1038/srep24193
59. Ceppi, M. et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic 
cells. Proc Natl Acad Sci USA 106, 2735–2740 (2009).
60. Turner, M. L., Schnorfeil, F. M. & Brocker, T. MicroRNAs regulate dendritic cell differentiation and function. J Immunol 187, 
3911–3917 (2011).
61. Basu, J., Shin, D. M. & Jo, E. K. Mycobacterial signaling through toll-like receptors. Front Cell Infect Microbiol 2, 145 (2012).
62. Kapoor, N., Narayana, Y., Patil, S. A. & Balaji, K. N. Nitric oxide is involved in Mycobacterium bovis bacillus Calmette-Guerin-
activated Jagged1 and Notch1 signaling. J Immunol 184, 3117–3126 (2010).
Acknowledgements
We thank Dr. William R. Surin and members of FACS facility, Indian Institute of Science, Bangalore for their 
help. The following reagent was obtained through BEI Resources, NIAID, NIH: Mycobacterium bovis, Strain AF 
2122/97 (ATCC® BAA-935™ ), Gamma-Irradiated Whole Cells, NR-31210. This study is supported by funds 
from the Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA: Reference No: 4803-1) 
(J.B. and K.N.B.); Department of Biotechnology (DBT), Government of India. Infrastructure support from ICMR 
(Center for advanced study in Molecular Medicine), DST (FIST) and UGC (special assistance) (K.N.B.); Institut 
National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie and Université 
Paris Descartes, Paris, France (J.B.); fellowship from IISc (S.H.) and IFCPAR/CEFIPRA (S.H. and E.S.V.) are 
acknowledged.
Author Contributions
S.H. designed and performed experiments, analyzed data, wrote the manuscript. E.S.V. and P.P. performed 
experiments and analyzed data. M.S., C.S. and V.U. performed experiments. S.V.K. analyzed the data. J.B. and 
K.N.B. designed experiments, analyzed data, wrote the manuscript and supervised the study.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Holla, S. et al. Mycobacteria-responsive sonic hedgehog signaling mediates 
programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion. Sci. Rep. 6, 24193;  
doi: 10.1038/srep24193 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
